Italian Register for the Study of Complicated Intra-Abdominal Infections

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-01-01

Study Completion Date

2020-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study will identify the epidemiological and treatment profiles of acute peritonitis in Italy

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Multicentre Observational Study on Community Acquired Intraabdominal Infections Management

NCT03544203

Intraabdominal Infections

COMPLETED

Italian National Study on the Critically Ill Liver Transplant Patient With an Infection

NCT03363646

Liver Transplantation Infection Sepsis +1 more

UNKNOWN

Role of Faecal Calprotectin in Patients With Abdominal Pain

NCT05795985

Inflammation

COMPLETED

Establishment of the Human Intestinal and Salivary Microbiota Biobank - Kidney Diseases

NCT04689074

Autosomal Dominant Polycystic Kidney Disease (ADPKD) Advanced-Chronic Kidney Disease (CKD) Diabetic Kidney Disease (DKD) +1 more

COMPLETED

Italian Study Group on Complicated Diverticulosis

NCT01276886

Diverticulitis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary objectives of the study are: (1) the identification of specific risk factors for in-hospital mortality, in order to perfect the clinical management of patients with complicated intra-abdominal infections (cIAIs); (2) the identification of specific risk factors for multi-drug resistant organisms (MDROs) isolation in patients with cIAIs, in order to improve the adequacy of empirical antimicrobial therapy.

The secondary objectives are: (1) the description of the clinical, diagnostic and treatment profiles of patients with cIAIs in Italian surgical departments; (2) the analysis of epidemiology and patterns of antimicrobial susceptibility of the microorganisms isolated in samples in intra-operative samples of peritoneal fluid or purulent exudate/discrete abscesses in patients with cIAIs; (3) the identification of specific risk factors for post-operative complications in patients with cIAIs.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Complicated Intra-abdominal Infections

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Epidemiological/treatment profiles

All consecutively hospitalized adult patients (older than 18 years of age) undergoing surgery, interventional drainage or conservative treatment, with diagnosis of cIAIs (defined as abdominal infections originating in an organ cavity, extending into the peritoneal space, and forming an abscess or peritonitis, will be included in the study.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

All consecutively hospitalized adult patients (older than 18 years of age) undergoing surgery, interventional drainage or conservative treatment, with diagnosis of cIAIs (defined as abdominal infections originating in an organ cavity, extending into the peritoneal space, and forming an abscess or peritonitis)